Spero Therapeutics, Inc. (FRA:2HA)
Germany
· Delayed Price · Currency is EUR 1.900
+0.022 (1.17%)
At close: Dec 5, 2025
Spero Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -43.84 | -68.57 | 22.81 | -46.42 | -89.76 | -78.28 | Upgrade
|
| Depreciation & Amortization | - | 0 | 0.37 | 0.87 | 0.65 | 0.76 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.59 | - | 5.31 | 0.64 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.01 | 0.25 | -0.03 | Upgrade
|
| Stock-Based Compensation | 4.82 | 7.79 | 7.93 | 9.12 | 9.43 | 4.89 | Upgrade
|
| Other Operating Activities | 1.1 | 1.04 | 0.97 | 5.96 | 2.22 | 0.26 | Upgrade
|
| Change in Accounts Receivable | 52.36 | 46.35 | -95.74 | 1.55 | 3.05 | 2.43 | Upgrade
|
| Change in Accounts Payable | -4.7 | 5.93 | 0.76 | -0.48 | -0.05 | -2.98 | Upgrade
|
| Change in Unearned Revenue | -28.55 | -26.63 | 29.01 | 21.89 | 10.64 | - | Upgrade
|
| Change in Income Taxes | 0.07 | -0.21 | 0.39 | - | 0.78 | -0.25 | Upgrade
|
| Change in Other Net Operating Assets | -9.54 | 10.84 | -4.79 | -0.87 | -1.56 | -12.67 | Upgrade
|
| Operating Cash Flow | -27.67 | -23.44 | -33 | -7.73 | -64.35 | -85.87 | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -0.16 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.04 | - | Upgrade
|
| Investment in Securities | - | - | - | 33.81 | 7.63 | 10.63 | Upgrade
|
| Investing Cash Flow | - | - | - | 33.81 | 7.67 | 10.47 | Upgrade
|
| Issuance of Common Stock | - | - | 0.22 | 24.93 | 36.82 | 80.85 | Upgrade
|
| Other Financing Activities | - | - | - | -54.49 | 47.23 | -0.95 | Upgrade
|
| Financing Cash Flow | - | - | 0.22 | -29.55 | 84.05 | 130.88 | Upgrade
|
| Net Cash Flow | -27.67 | -23.44 | -32.77 | -3.48 | 27.38 | 55.48 | Upgrade
|
| Free Cash Flow | -27.67 | -23.44 | -33 | -7.73 | -64.35 | -86.03 | Upgrade
|
| Free Cash Flow Margin | -68.25% | -48.86% | -31.79% | -14.45% | -352.47% | -922.07% | Upgrade
|
| Free Cash Flow Per Share | -0.50 | -0.43 | -0.62 | -0.21 | -2.08 | -3.84 | Upgrade
|
| Cash Income Tax Paid | 0.1 | 0.1 | 2.21 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -7.34 | -25.13 | -9.9 | -1.08 | -41.44 | -55.16 | Upgrade
|
| Unlevered Free Cash Flow | -7.34 | -25.13 | -9.9 | 0.55 | -40.22 | -55.16 | Upgrade
|
| Change in Working Capital | 9.65 | 36.28 | -70.38 | 22.09 | 12.86 | -13.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.